Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted The Doherty Institute’s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues The trials have been expedited to mid-2021 with Federal Government funding

Australia to trial ‘backup’ COVID-19 vaccines that can be modified to fight virus mutations – ABC News